Vitak, Maastricht University
Innovative Medical Devices
Innovation & Research
MGP Center
Human Trial Center: ICHIS
Education
Measurements & Resources

Patent history

Patents that have previously been developed and sold to various commercial parties include:

  1. Method for the extraction of a vitamin K-dependent carboxylase complex and the use thereof. Sold to: Karl Thomae GmbH, Biberach, Germany.

  2. Chemical compound used for prevention and/or treatment of arteriosclerosis, consisting of the follwing derivative of Menatetrenone as an active ingredient. Sold to: Eisai Co., Ltd. Tokyo, Japan.

  3. Dietetic foods and pharmaceutical preparations inhibiting blood coagulation. Sold to: CPC-Europe, Heilbronn, Germany.

  4. Method for immunological assaying of human Matrix Gla-Protein and its use as a biomarker. Sold to: IDS, Boldon, UK.

  5. Compositions comprising vitamin K. Sold to Novartis, Basel, Switzerland.

  6. Diagnostic assay for human matrix gla-protein and its use as a biomarker. Sold to: IDS, Boldon, UK.

  7. Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification. Sold to: NattoPharma ASA, Hovik, Norway.

  8. Vitamin K2 containing food product. Sold to: NattoPharma ASA, Hovik, Norway.

  9. New delivery systems for vitamins and other trace elements to counteract deficiencies and to prevent chronic diseases. Withdrawn after publication.

  10. Compositions comprising vitamin K for treating or preventing age-related stiffening of the arteries. Sold to: NattoPharma ASA, Hovik, Norway.

  11. Pharmaceutical and nutraceutical products comprising vitamin K2. Sold to: NattoPharma ASA, Hovik, Norway.